2018 American Transplant Congress
A Six-Month, Prospective, Single-Center, Pilot Study to Determine the Pharmacokinetics and Effectiveness of Immunosuppressant Regimens in Liver Transplantation Patients Receiving Twice-Daily Tacrolimus and Everolimus (TAC + EVR BID) Regimen Converted to Once-Daily Tacrolimus and Everolimus (TAC + EVR QD) Regimen – A Priliminary Report
Adherence to immunosuppressant regimen is crucial for graft survival and usually inversely related to the dose frequency. Similar efficacy and safety profile has been approved…2018 American Transplant Congress
Clinical Outcomes of Late Conversion to Once-Daily Tacrolimus after Liver Transplant
BackgroundSince a once-daily tacrolimus (TAC-OD) has been introduced in the field of transplantation, many studies reported advantages of the new drug, such as the better…2018 American Transplant Congress
Once-Daily Prolonged-Release Tacrolimus versus Twice-Daily Tacrolimus in Liver Transplantation: A Meta-Analysis
Background: A prolonged-release formulation of tacrolimus has been developed to provide once-daily dosing, with similar efficacy and safety to the standard twice-daily dosing and it…2018 American Transplant Congress
Liver Transplantation in Foreign Nationals: Lower Rates of Waitlist Mortality and Higher Rates of Lost to Follow-Up Post-Transplant
University of Pennsylvania, Philadelphia.
Background: A highly contentious issue in the transplant community is whether or not to provide deceased donor liver transplant (DDLT) to non-citizen/non-residents (NCNRs) who travel…2018 American Transplant Congress
The Impact of Spontaneous Bacterial Peritonitis on Patient Outcomes after Liver Transplantation Using the Scientific Registry of Transplant Recipient (SRTR) Database
Spontaneous bacterial peritonitis (SBP) is associated with abdominal inflammation and increased morbidity in patients with end-stage liver disease. However, SBP has generally not been associated…2018 American Transplant Congress
Ethnic and Age Disparities in Outcomes among Liver Transplant Waitlist Candidates
1University of Alabama at Birmingham, Birmingham; 2Department of Veterans Affairs, Washington DC.
Background: Despite the increasing prevalence of end-stage liver disease (ESLD) in older adults, there is no consensus to determine suitability for liver transplantation (LT) in…2018 American Transplant Congress
Validation of the alpha-Fetoprotein Model for Hepatocellular Carcinoma Recurrence after Transplantation in an Asian Population
Department of Surgery, Samsung Medical Center, Seoul, Republic of Korea.
Background: This study was designed to validate the alpha-fetoprotein model for predicting recurrence after LT in Korean HCC patients.Methods: Patients who underwent liver transplantation for…2018 American Transplant Congress
First-Time Simultaneous vs. Sequential Liver-Kidney Transplantation in Polycystic Kidney Disease: A Review of the UNOS Database
1Baylor College of Medicine, Houston, TX; 2Texas Children's Hospital, Houston, TX.
Introduction. Polycystic disease (PKD) may necessitate the need for liver and/or kidney transplantation. The long-term outcomes of simultaneous liver-kidney transplantation (SLK) and kidney-after-liver (KAL) or…2018 American Transplant Congress
Specialized Transplant Critical Care Model Improves Access to Transplantation and Short-Term Survival Outcomes after Liver Transplantation in the Highest Acuity Patients
Objective: Liver transplantation (LT) is a lifesaving treatment for end stage liver disease (ESLD). High acuity ESLD patients are disadvantaged as they are frequently denied…2018 American Transplant Congress
Cannabis Use in Liver Transplant Recipients: A Single Center Experience
Division of Liver and Pancreas Transplant, David Geffen School of Medicine, LA, CA.
Introduction: Cannabis is one of the most commonly used illicit drugs worldwide. In the US, cannabis has gained wider social and political acceptance. Liver transplant…
- « Previous Page
- 1
- …
- 772
- 773
- 774
- 775
- 776
- …
- 1683
- Next Page »